1. International variability in the reimbursement of cancer drugs by publically funded drug programs;Cheema;Curr Oncol,2012
2. Coleman MP, Alexe D-M, Albreht T, et al. Responding to the challenge of cancer in Europe. 2008. Available from: http://www.euro.who.int/__data/assets/pdf_file/0011/97823/E91137.pdf. [Accessed March 1, 2016].
3. Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5—a population-based study;De Angelis;Lancet Oncol,2014
4. Variations in cancer survival and patterns of care across Europe: roles of wealth and health-care organization;Gatta;J Natl Cancer Inst Monogr,2013
5. Kanavos P. Differences in costs of and access to pharmaceutical products in the EU. 2011. Available from: http://www.europarl.europa.eu/RegData/etudes/etudes/join/2011/451481/IPOL-ENVI_ET(2011)451481_EN.pdf. [Accessed March 1, 2016].